Infectologia

Interested in recent trends in the management of acute diverticulitis? Brand new review 👇 #openaccess https://t.co/hdA60Ko3sI @PaulinaSalminen @villesallinen @henrikthorlaci1 @KariTikkinen @MalinASund @YaqubSheraz @PeterStalberg @me4_so pic.twitter.com/HLDBoc9WSo

— Scandinavian Journal of Surgery (@ScandJSurg) July 29, 2021

Revisão sistemática | Não há evidências que suportem o uso de ivermectina no tratamento ou na prevenção de COVID-19.

2 Ago, 2021 | 17:48h

Ivermectin for preventing and treating COVID‐19 – Cochrane Library

Resumo: Ivermectin for preventing and treating COVID-19 – Cochrane Library

Comentário: Ivermectin treatment in humans for COVID-19 – Liverpool School of Tropical Medicine

Conteúdos relacionados:

Why was a major study on ivermectin for covid-19 just retracted?

RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”.

Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19

Estudo randomizado PRINCIPLE | Doxiciclina não melhora os desfechos de pacientes ambulatoriais com suspeita de COVID-19.

2 Ago, 2021 | 17:44h

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet Respiratory Medicine

Comentário: PRINCIPLE: a community-based COVID-19 platform trial – The Lancet Respiratory Medicine

Comentário no Twitter

NEW Research—In suspected #COVID19 in the community, doxycycline was not associated with clinically meaningful reductions in time to recovery or hospital admissions or deaths, and should not be used as a routine treatment

Read the PRINCIPLE trial here https://t.co/Osw1hZLCaY pic.twitter.com/Q3VrpAO9cm

— The Lancet Respiratory Medicine (@LancetRespirMed) July 28, 2021

Diretriz atualizada da OMS SAGE sobre como alocar vacinas contra COVID-19 no contexto de suprimentos limitados.

2 Ago, 2021 | 17:43h

WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply – World Health Organization

Falsas dicotomias da COVID-19 e uma revisão ampla das evidências a respeito de saúde pública, sintomatologia da COVID-19, transmissão do SARS-CoV-2, uso de máscara e reinfecção.

2 Ago, 2021 | 17:41h

COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection – BMC Infectious Diseases

Comentário no Twitter

A false dichotomy is a logical fallacy that involves presenting only two views or options when other possibilities exist.

Here are 6 COVID-19 false dichotomies:https://t.co/7uYry96l2q by @KevinEscandonMD @angie_rasmussen @BogochIsaac @EpiEllie @SaskiaPopescu @KindrachukJason pic.twitter.com/mHanKxObmt

— Dr. Jonathan N. Stea (@jonathanstea) July 28, 2021

“Breakthrough infections” (infecções em indivíduos já vacinados) por Covid-19 em trabalhadores da área da saúde.

2 Ago, 2021 | 17:39h

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers – New England Journal of Medicine

Comentário no Twitter (fio – clique para saber mais)

Very important @NEJM paper today on breakthrough infections (BTI) post-vaccination in Israeli health care workers.
5 key points:
1. Of ~1500 people, 0.4% had BIs, sequenced to be Alpha 85% (this was pre-Delta)https://t.co/l69DK5Cbv4 pic.twitter.com/zDSq5e0baN

— Eric Topol (@EricTopol) July 28, 2021

O que é “breakthrough infection”? 6 questões e respostas sobre infecções por SARS-CoV-2 adquiridas após vacinação.

2 Ago, 2021 | 17:38h

What is a breakthrough infection? 6 questions answered about catching COVID-19 after vaccination – The Conversation

Vacinas contra COVID-19 diminuem a disseminação viral, mas a variante Delta é um fator desconhecido – “Estudos mostram que as vacinas reduzem a disseminação do SARS-CoV-2 em mais de 80%, mas a variante Delta está criando uma nova incerteza.”

2 Ago, 2021 | 17:36h

COVID vaccines slash viral spread – but Delta is an unknown – Nature

Israel irá aplicar a 3ª dose de reforço da vacina contra COVID em idosos.

Estudo randomizado | Em gestantes com infecção primária por citomegalovírus (CMV) diagnosticada antes de 24 semanas de gestação, a infusão de globulina hiperimune de CMV não previne a infecção congênita.

Revisão | Mudança de paradigmas no tratamento da diverticulite aguda não complicada.